On Invalid Date, Rallybio (NASDAQ: RLYB) reported Q4 2023 earnings per share (EPS) of -$0.49, up 11.36% year over year. Total Rallybio earnings for the quarter were -$20.24 million. In the same quarter last year, Rallybio's earnings per share (EPS) was -$0.44.
As of Q2 2024, Rallybio's earnings has grown year over year. Rallybio's earnings in the past year totalled -$74.56 million.
What is RLYB's earnings date?
Rallybio's earnings date is Invalid Date. Add RLYB to your watchlist to be reminded of RLYB's next earnings announcement.
What was RLYB's revenue last quarter?
On Invalid Date, Rallybio (NASDAQ: RLYB) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Rallybio's revenue was $0.00.
What was RLYB's revenue growth in the past year?
As of Q2 2024, Rallybio's revenue has grown null year over year. Rallybio's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.